Siblings 圖書 [1/1] 會議論文/會議摘要 [17/28] Collection Statistics 近3年內發表的文件:11(15.94%) 含全文筆數:68(98.55%) 文件下載次數統計 下載大於0次:68(100.00%) 下載大於100次:63(92.65%) 檔案下載總次數:22847(78.34%) 最後更新時間: 2025-04-30 01:33 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Construction of hot tumor classific... Comparative impact of tertiary lymp... The correlation between LAG-3 expre... Registry of genetic alterations of ... Systemic treatments in pancreatic c... The experience of neoadjuvant chemo... Real-world data validation of NAPOL... Elevated PD-L1 expression and micro... Adjuvant therapy in biliary tract c... The association between UGT1A1 poly...

跳至: (選擇年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 69. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2025-02-21	Construction of hot tumor classification models in gastrointestinal cancers	Journal of Translational Medicine. 2025 Feb 21;23:Article number 218.
2025-01-27	Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma	Journal for Immunotherapy of Cancer. 2025 Jan 27;13:Article number e010173.
2025-01	The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer	Cancer Immunology Immunotherapy. 2025 Jan;74(2).
2024-09-30	Registry of genetic alterations of Taiwan non-small cell lung cancer by comprehensive next-generation sequencing: A real-world cohort study-Taiwan cooperative oncology group T1521	JCO Global Oncology. 2024 Sep 30;10:Article number e2400125.
2024-06	Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation	Biomedical Journal. 2024 Jun;47(3):Article number 100696.
2023-09-01	The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer. a cross sectional study	International Journal of Surgery. 2023 Sep 1;109(9):2614-2623.
2023-04	Elevated PD-L1 expression and microsatellite instability in elderly patients with gastric cancer	Journal of Immunotherapy. 2023 Apr;46(3):111-119.
2023-02-05	Real-world data validation of NAPOLI-1 nomogram for the prediction of overall survival in metastatic pancreatic cancer	Cancers. 2023 Feb 5;15(4):Article number 1008.
2023-02	The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan	ESMO Open. 2023 Feb;8(1):Article number 100746.
2023-01-21	Adjuvant therapy in biliary tract cancers: Oral fluoropyrimidine as a beginning	Lancet. 2023 Jan 21-27;401(10372):170-171.
2023-01	A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer	Neoplasia. 2023 Jan;35:Article number 100856.
2022-12-15	An integrated microfluidic system for cholangiocarcinoma diagnosis from bile by using specific affinity probes	Sensors and Actuators B-Chemical. 2022 Dec 15;373:Article number 132724.
2022-11-01	Revisiting the cerebral hemodynamics of awake, freely moving rats with repeated ketamine self-administration using a miniature photoacoustic imaging system	Neurophotonics. 2022 Nov 01;9(4):Article number 045003.
2022-11	CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer	British Journal of Cancer. 2022 Nov;127(9):1615-1628.
2022-10	The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma	Hepatology International. 2022 Oct;16(5):1137-1149.
2022-10	Impaired chromatin remodeling predicts better survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract Cancer: A phase II T1219 study	Clinical Cancer Research. 2022 Oct 3;28(19):4248-4257.
2022-09-15	Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin	American Journal of Cancer Research. 2022 Sep 15;12(9):4267-4278.
2022-09	A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study	European Journal of Cancer. 2022 Sep;173:123-132.
2022-06-26	The differential clinical impacts of cachexia and sarcopenia on the prognosis of advanced pancreatic cancer	Cancers. 2022 Jun 26;14(13):Article number 3137.
2022-06-22	Dosing pattern and early cumulative dose of liposomal irinotecan in metastatic pancreatic cancer: A real-world multicenter study	Frontiers in Oncology. 2022 Jun 22;12:Article number 800842.
2022-06-16	Cancer-cell-derived cell-free DNA can predict distant metastasis earlier in pancreatic cancer: A prospective cohort study	Therapeutic Advances in Medical Oncology. 2022 Jun 16;14:1-13.
2022-06-02	Transferrin and prealbumin identify esophageal cancer patients with malnutrition and poor prognosis in patients with normal albuminemia: A cohort study	Nutrition and Cancer. 2022 Jun 2;74(10):3546-3555.
2022-06	Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin	Journal of Hepato-Biliary-Pancreatic Sciences. 2022 Jun;54(5):607-612.
2022-05-15	Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: A single institution experience	American Journal of Cancer Research. 2022 May 15;12(5):2189-2202.
2022-04-15	The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan	American Journal of Cancer Research. 2022 Apr 15;12(4):1884-1898.

顯示項目1-25 / 69. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目